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1. Introduction
  Visceral leishmaniasis (VL) is the most severe form of 
leishmaniasis and has a fatality rate as high as 100% within 
two years if left untreated. The mortality rate for the disease 
can be reduced with early diagnosis and appropriate 
treatment[1]. Epidemiological studies have shown that 
Mediterranean VL caused by L. infantum occurs in different 
parts of Iran, and domestic dogs are the principal source of 
the infection[2].
  The direct agglutination test (DAT) is an easily performed, 
highly sensitive, specific, reliable and cost-effective 
technique for the diagnosis and seroepidemiological study 
of VL in humans and dogs across different geographical 
regions[3-9].
  However, use of the DAT has been limited because of its 
susceptibility to fluctuating temperature conditions and 
requirement for cold chain facilities, which may not be 
present in regions with endemic VL. A freeze-dried DAT 
antigen has been evaluated in the field and found to be 
adequately stable for long periods of time at temperatures 
up to 45 曟, but preparation of this antigen requires 
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sophisticated equipment, a continuous electrical supply and 
a high level of laboratory expertise[10].
  In the present study, we report, for the first time, a 
glycerol-preserred (GP)-DAT antigen derived from an Iranian 
strain of L. infantum. The antigen was stored at various 
temperatures, and its ability to detect anti-L. infantum 
antibodies in cases of Iranian VL and canine visceral 
leishmaniasis (CVL) was compared with that of freeze dried 
(FD)-DAT and formaldehyde-fixed(FF)-DAT antigens.
2. Materials and methods
2.1. Study design
  In this study, we evaluated the use of glycerol for the 
long-term preservation of DAT antigen. GP-DAT antigen 
was stored at 4 曟, 22-37 曟 or 50 曟 immediately after 
preparation and subsequently used to detect the presence of 
anti-Leishmania antibodies in positive and negative pooled 
human and dog sera collected from different parts of Iran. 
Over a period of 365 days, the GP-DAT antigen was evaluated 
12 times at monthly intervals. The results for GP-DAT and 
FD-DAT antigens kept at ambient temperatures (22-37 曟
) and FF-DAT antigen stored at 4 曟 were presented. To 
determine the specificity of GP-DAT antigen for detecting 
anti-Leishmania antibodies, forty-one sera from patients 
with infectious diseases other than VL and 10 healthy 
control sera were used. 
2.2. Subjects
  The study was conducted in accordance with the 
Declaration of Helsinki and approved by the Ethics 
Committee of the Tehran University of Medical Sciences 
in Tehran, Iran. Bone marrow and 2-3 mL of venous blood 
were collected from humans suspected to have VL and from 
domestic dogs in areas with endemic VL in the northwest 
and southern parts of Iran. 
  Sera from forty-one individuals with cutaneous 
leishmaniasis (n=12), hydatidosis (n=5), malaria (n=4), 
leprosy (n=4), toxoplasmosis (n=3), hepatitis B (n=3), 
tuberculosis (n=5), fascioliasis (n=3), HIV+ (n=1) or 
borreliosis (n=1) were used to determine the specificity of 
GP-DAT antigen for detecting anti-Leishmania antibodies 
compared with FD-DAT and FF-DAT antigens.
  Eighty qualified sera (40 human sera and 40 dog sera), 
out of 729 total serum samples collected from different 
geographical zones in Iran from 2007-2009, were used to 
make pooled sera. Each pooled serum contained 10 sera. All 
sera were separated from the blood samples and kept frozen 
until they were sent to the laboratory.
  All pooled sera were tested in duplicate using GP-DAT, FF-
DAT and FD-DAT antigens at the School of Public Health at 
the Tehran University of Medical Sciences.
2.3. Preparation of DAT antigens-FF-DAT antigen -GP-
DAT antigen
  The L. infantum  antigens were prepared in the 
leishmaniasis laboratory at the School of Public Health at 
the Tehran University of Medical Sciences.
  The principal steps for making DAT antigen were the 
mass production of promastigotes of the Iranian strain of 
L. infantum [MCAN/IR/07/Moheb-gh. (GenBank accession 
no. FJ555210)] in RPMI 1640 medium (Biosera, South 
America) containing 10% fetal calf serum (Biosera, South 
America), trypsinization of the parasites, staining with 
coomassie brilliant blue R-250 (Sigma, USA) and fixing with 
1.2% formaldehyde[2,3].
  Antigen was prepared under the same conditions as 
standard FF-DAT antigen, but after centrifugation of FF-
DAT, the pellet was mixed with 1.2% (v/v) formalin citrate 
saline and preserved with 75% glycerol (Merck Lot No. 
217K17776791) at 5伊108 promastigotes/mL[11]. The GP-DAT 
antigen was divided into 0.5 ml aliquots; these vials were 
then stored at the ambient laboratory temperature (22-37 曟),
4 曟 and 50 曟 for up to 12 months.
2.4. FD-DAT antigen
  Twenty 5 mL vials of FD antigen (KIT Royal tropical 
Institute, Lot No. 0904, Netherland) were kindly provided 
by the Eastern Mediterranean Health Regional-World 
Health Organization (EMRO/WHO) as a gift and delivered 
to us by the office of the World Health Organization in 
Iran (Dr. Manenti). The FD antigens were stored at ambient 
temperatures (22-37 曟) in the leishmaniasis laboratory at 
the School of Public Health, Tehran University of Medical 
Sciences in Tehran, Iran.
2.5. DAT performance
  Monthly tests were performed between September 2009 and 
August 2010. To reconstitute the FD antigen, 5 mL of normal 
saline (0.9% NaCl) was added to each vial two days before 
testing. Glycerol-preserved antigen was reconstituted by 
adding 9 volumes of 1.2% (v/v) formalin citrate saline before 
testing.
  The pooled human sera were diluted over a range of 1:100 
to 1:102 400 with normal saline (0.9% NaCl) containing 0.2% 
gelatin and 0.78% 毬-mercaptoethanol (2-ME) (Sigma Lot 
No. 45H0508). The pooled canine sera were diluted from 1:10 
to 1:204 80 with the same diluents, but 1.56% 2-ME were 
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added to the V-shape microtiter plates. The dog sera plates 
were incubated for 1 h at 37 曟.
  After adding the respective antigens, the microplates were 
manually shaken for one minute. Following 24 h incubation 
under ambient temperatures and moist conditions, the 
results were assessed[12,13]. The highest dilution showing 
agglutination was considered to be the titer. The positive 
controls were clinically, parasitologically (by microscopy 
and culture) and serologically (DAT, IFA and rK39) positive. 
No anti-Leishmania antibodies were detected in sera 
collected from healthy control subjects who lived in areas 
without endemic VL.
  Glycerol-preserved DAT antigen was compared with FD-
DAT and FF-DAT antigens. The results were read by at least 
two observers, and the titers were expressed as reciprocals 
of the highest dilution showing definite agglutination.
2.6. Data analysis
  Statistical analyses were conducted using SPSS software 
version 13.5 (SPSS Inc., Chicago, IL, USA), with a probability 
(P) value of less than 0.05 considered to be statistically 
significant. The degree of agreement was determined by 
calculating the total number of positive samples with both 
antigens plus the total number of negative samples with both 
antigens divided by the total number of samples, using a 
95% confidence interval.
3. Results
  Glycerol was found to be an effective long-term 
preservative. Regarding storage temperature, DAT titers 
obtained with antigen preserved in 75% (v/v) glycerol 
against positive (n=6) and negative (n=2) pooled sera were 
compared to titers from FD-DAT and FF-DAT antigens. 
  All 6 positive pooled sera prepared from 30 confirmed VL 
patients and 30 infected domestic dogs with different anti-
Leishmania antibody titers showed positive reactions to both 
FD-DAT and GP-DAT antigens stored at 4 曟 and with GP-
DAT antigens stored at 22-37 曟 for a period of 12 months; 
however, 75% of FF-DAT antigens showed positive reactions 
to both human and dog positive pooled sera. Interestingly, 
25.0% and 33.3% of confirmed human and dog pooled sera 
were detected with GP-DAT antigen stored at 50 曟 for 
the first month after preparation. The glycerol-preserved 
antigen stored at 4 曟 and 22-37 曟 showed higher titers 
than the FF-DAT antigen, although storage of GP-DAT 
antigen at 22-37 曟 did not produce autoagglutination. 
The results show that the FF-DAT antigen detected anti-
L. infantum antibodies in human and dog sera for 6 months 
after preparation while the GP-DAT antigens stored at 4 曟
and 22-37 曟were stable for at least 12 months.
  With the exception of GP-DAT antigen stored at 50 曟, 
DAT results were highly reproducible at the time of survey 
(weighted kappa: GP= 0.833, FD= 0.979 and FF= 0.917). 
  No anti-L. infantum antibodies were detected in sera 
collected from 41 patients with infectious diseases other 
than VL or from 10 healthy controls by GP-DAT, FD-DAT or 
FF-DAT antigens. 
4. Discussion
  Direct agglutination tests were introduced three decades 
ago using an antigen suspension composed of promastigote 
forms of Leishmania donovani for the detection of VL, 
but this technique required that the antigen be stored 
and transported in a cold chain[3]. The FD-DAT antigen 
was introduced to solve this problem; however, the major 
drawbacks of freeze-dried antigen are the requirement of 
sophisticated equipment, a continuous electrical supply and 
a high level of laboratory expertise[10,14].
  A simple and economical method for making DAT antigen 
from L. donovani to detect anti-Leishmania antibodies 
was successfully introduced by Harith et al in Sudan for 
Kala-azar sufferers[15] and for PKDL in India[14]. Here, a 
GP-DAT antigen was prepared from an Iranian strain of 
L. infantum and stored at different temperatures for the 
purpose of detecting anti-L. infantum antibodies in positive 
and negative pooled sera collected from Iranian VL cases, 
patients with other infectious diseases, healthy controls and 
canine VL cases.
  In order to decrease the influence of genetic variations 
in human and canine hosts, which is the most critical 
confounding factor in the study of this disease in diverse 
geographical regions[8,16-22], the positive pooled sera were 
collected from different areas with endemic VL and negative 
pooled sera were collected from areas without endemic VL.
  It seems that long-term maintenance of GP-DAT antigen 
stored at 22-37 曟 and 4 曟 compared to FF-DAT antigen is 
related to the potentially protective effects of glycerol on the 
intact promastigote L. infantum that is used for DAT antigen 
preparation. 
  The GP-DAT antigen stored at 50 曟 was of unacceptable 
quality; this is likely due to high temperatures having 
destroyed the antigen, which lead to decreased test 
sensitivity during the initial stages of the study.
  In conclusion, GP-DAT antigen stored at 22-37 曟 is 
highly stable at fluctuating laboratory temperatures, easy to 
transport and can be used for the serodiagnosis of human 
and canine VL without the requirement for specialized 
equipment for transportation or maintenance of a cold chain.
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